Search - tctmd.com

Displaying 501 - 520 of 977

Sort: Relevancy | Date

News Daily News

多支血管病变的非糖尿病患者中 CABG 的生存优势强于 PCI

L.A. McKeown

June 29, 2016

News Daily News

New Analysis Bolsters Evidence Backing the Safety of Multivessel PCI in STEMI

Todd Neale

June 29, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

L.A. McKeown

June 29, 2016

Presentation

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Presenter: Mineok Chang

June 28, 2016

News Daily News

Prior Radiation Therapy for Cancer Increases Mortality Risk After PCI

L.A. McKeown

June 21, 2016

News Daily News

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

Caitlin E. Cox

May 26, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Caitlin E. Cox

May 26, 2016

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Daily News

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Yael L. Maxwell

May 13, 2016

News Daily News

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

Yael L. Maxwell

May 13, 2016

News Daily News

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Yael L. Maxwell

May 13, 2016

News Daily News

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Michael O'Riordan

April 25, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Daily News

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Todd Neale

March 15, 2016

Advertisement

多支血管病变的非糖尿病患者中 CABG 的生存优势强于 PCI

New Analysis Bolsters Evidence Backing the Safety of Multivessel PCI in STEMI

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Prior Radiation Therapy for Cancer Increases Mortality Risk After PCI

现代 PCI 当中加入 SYNTAX 评分 II 对三支病变患者有益

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content